Altimmune (ALT) Other Accumulated Expenses (2014 - 2026)
Altimmune (ALT) posted Other Accumulated Expenses of $313,000 for Q2 2026, up 71.0% from $183,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Altimmune (ALT) Other Accumulated Expenses (2014 - 2026) Analysis & Trends
At the end of FY2025, Altimmune's Other Accumulated Expenses came in at $315,000, up 472.7% from FY2024.
- Annual Other Accumulated Expenses shows a three-year compound annual growth rate of 45.2% (FY2022 to FY2025).
- In prior years, Altimmune's Other Accumulated Expenses was $55,000 in FY2024 (-55.6%), $124,000 in FY2023 (+20.4%) and $103,000 in FY2022.
- Quarterly Other Accumulated Expenses has run from a low of $54,000 in Q3 2024 to a high of $315,000 in Q4 2025 over five years.
- On a year-over-year basis, Other Accumulated Expenses has increased in each of the last five quarters, with growth averaging 189.3% over the last seven quarters.
- The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q4 2025, with growth of 472.7%; the weakest was Q4 2024, with a decline of 55.6%.
- According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $313,000 (Q1 2026), $315,000 (Q4 2025) and $177,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Altimmune | 530.91 Mn | 530.91 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 313,000.00 |
| Mar 31, 2026 | 313,000.00 |
| Dec 31, 2025 | 315,000.00 |
| Sep 30, 2025 | 177,000.00 |
| Jun 30, 2025 | 183,000.00 |
| Mar 31, 2025 | 56,000.00 |
| Dec 31, 2024 | 55,000.00 |
| Sep 30, 2024 | 54,000.00 |
| Jun 30, 2024 | 69,000.00 |
| Mar 31, 2024 | 66,000.00 |
| Dec 31, 2023 | 124,000.00 |
| Dec 31, 2022 | 103,000.00 |
| Mar 31, 2018 | 67,620.00 |
| Dec 31, 2017 | 328,384.00 |
| Mar 31, 2017 | 11,588.00 |
| Dec 31, 2016 | 169,790.00 |
| Sep 30, 2016 | 11,588.00 |
| Jun 30, 2016 | 11,588.00 |
| Dec 31, 2015 | 11,250.00 |
| Jun 30, 2015 | 74,233.00 |
API Access
Altimmune Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();